Font Size:
a
A
A
Keyword [reprogramming]
Result: 81 - 100 | Page: 5 of 10
81.
Research On The Function Of TET1Protein During Somatic Cell Reprogramming
82.
Molecular Mechanism For CD147-mediated Glucose Metabolic Reprogramming In Hepatocellular Carcinoma Cells
83.
Induced Pluripotent Stem Cells (iPSC) From Patients With Acute Myeloid Leukemia Based On Cellular Reprogramming
84.
The Induction Of Mouse IPS Cells By Controlled Folate Deprivation Method
85.
Reprogramming Of Human Adipose Mesenchymal Stem Cells To Induced Pluripotent Stem Cells Using A Polycistronic Plasmid
86.
Generation Of Induced Pluripotent Stem Cell-derived Mice By Reprogramming Of A Mature NKT Cell And Development And Function Analysis Of NKT Cells Developed From The Mice
87.
Epigenetic Reprogramming Effects Of Bovine Oocyte Extract On Human Lung Cancer Cells
88.
Molecular Mechanism For Cellular Reprogramming In Corneal Fibroblasts Induced By Lipopolysaccharide Pretreatment Modulating Antifungal Innate Immunity
89.
Induced Pluripotent Stem Cells Derived From Tumor Cells
90.
The Mechanisms MicroRNA In Embryonic Stem Cell Differentiation
91.
Generation Of Lentivirus Expressing Pri-mir-302/367Gene And Its Infecting In Human Cord Blood Mononuclear Cells
92.
The Role Of HDAC5in Mouse Embryonic Stem Cell Lineage Commitment And Somatic Reprogramming
93.
Induced Pluripotent Stem Cell Lines Derived From Human Urine Cells
94.
Antioxidant Treatment During Reprogramming Reduces Genomic Aberrations Of Human IPSCs
95.
MMPs Inhibitor Enhance Anti-CTLA-4Antibody Immunotherapy Of Breast Cancer By Reprogramming Tumor Microenvironment
96.
Non-genetic Direct Reprogramming And Biomimetic Platforms In A Preliminary Study For Adipose-derived Stem Cells Into Corneal Endothelia-like Cells
97.
Establishment Of Induced Pluripotent Stem Cell-like Cells From Guinea Pig
98.
Establishment Of Cloned Minipigs Models For Congenital Nephrotic Syndrome By Somatic Cell Nuclear Transfer
99.
Reprograming Research Of Somatic Cells And Tumor Cells AND Research On The Application Of CRISPR-Cas9 Technology In Acute Promyelocytic Leukemia
100.
Study Of Adolase B In Sorafenib Resistance Of Hepatocellular Carcinoma
<<First
<Prev
Next>
Last>>
Jump to